Target ALS was launched through initial funding of $26,127,162 over three years provided by our principal donors (Dan Doctoroff, David Rubenstein and Bloomberg Philanthropies) as well as others who have chosen to remain anonymous. This followed an earlier grant of $15,000,000 from Mr. Doctoroff and Bloomberg Philanthropies to the P2ALS consortium, which involved some of the same research groups. The extraordinary generosity of all these supporters has brought us to an exciting turning point in summer 2015. If you wish to be part of the next stage of this adventure, please follow this link: